Skip to main content

ENvue Medical, Inc.

FEED
Exchange
OTC
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001326706

No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding ENvue Medical, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of FEED: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders1810−8
SharesConverted for a 1-for-20 split118.3K59.5K−58.9K (−49.8%)
Value$593.0K$203.6K−$389.4K (−65.7%)

New holders (1)

Institutions that held ENvue Medical, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to FEED in Q1 2023
InstitutionSharesValue% of portfolio
Tower Research Capital LLC (TRC)806$3.00K0.00%

Sold out (9)

Institutions that held ENvue Medical, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of FEED in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
AWM Investment Company, Inc.901,069$225.3K
State Street Corp125,390$31.3K
Citadel Advisors LLC56,152$14.0K
Two Sigma Securities, LLC54,602$13.8K
Northern Trust Corp46,869$11.8K
Susquehanna International Group, LLP16,325$4.08K
Cambridge Investment Research Advisors, Inc.14,360$4.00K
StoneX Group Inc.12,395$3.12K
Psagot Value Holdings Ltd. / (Israel)9,720$2.00K